Scopolamine hydrochloride | CAS#55-16-3 | Muscarinic acetylcholine antagonist

MedKoo Cat#: 463940 | Name: Scopolamine hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Scopolamine hydrochloride is a competitive nonselective muscarinic acetylcholine antagonist. Scopolamine-induced amnesia in laboratory animals is a commonly-used model of memory deficit.

Chemical Structure

Scopolamine hydrochloride

CAS#55-16-3 (HCl)

Theoretical Analysis

MedKoo Cat#: 463940

Name: Scopolamine hydrochloride

CAS#: 55-16-3 (HCl)

Chemical Formula: C17H22ClNO4

Exact Mass: 339.1237

Molecular Weight: 339.82

Elemental Analysis: C, 60.09; H, 6.53; Cl, 10.43; N, 4.12; O, 18.83

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

114-49-8 (HBr) 55-16-3 (HCl) 51-34-3 (free) 6533-68-2 (HBr trihydrate)

Synonym

Scopolamine hydrochloride; Hyoscine hydrochloride;

IUPAC/Chemical Name

(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate hydrochloride

InChi Key

KXPXJGYSEPEXMF-MOUKNHLCSA-N

InChi Code

InChI=1S/C17H21NO4.ClH/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10;/h2-6,11-16,19H,7-9H2,1H3;1H/t11-,12-,13-,14+,15-,16+;/m1./s1

SMILES Code

CN1[C@@H]2C[C@@H](OC([C@@H](c3ccccc3)CO)=O)C[C@H]1[C@@H]4O[C@H]24.Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 339.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kmet OG, Filipets ND, Kmet TI, Vepriuk YM, Vlasova KV. BIOCHEMICAL AND MORPHOLOGICAL MARKERS OF EXPERIMENTAL SCOPOLAMINE-INDUCED NEURODEGENERATION AND THE EFFECT OF ENALAPRIL ON THEM. Wiad Lek. 2020;73(10):2114-2119. PMID: 33310932. 2: Hino N, Marumo T, Kotani M, Shimazaki T, Kaku-Fukumoto A, Hikichi H, Karasawa JI, Tomishima Y, Komiyama H, Tatsuda E, Nozawa D, Nakamura T, Chaki S. A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents. J Pharmacol Exp Ther. 2020 Nov;375(2):276-285. doi: 10.1124/jpet.120.000185. Epub 2020 Aug 29. PMID: 32862143. 3: Yao YT, Ying H, Fang NX, Zhang YB, Yuan X. Penehyclidine Hydrochloride Premedication Is Not Associated with Increased Incidence of Post-Operative Cognitive Dysfunction or Delirium:A Systemic Review and Meta-Analysis. Chin Med Sci J. 2020 Jun 30;35(2):121-134. doi: 10.24920/003630. PMID: 32684232. 4: Rolle CE, Fonzo GA, Wu W, Toll R, Jha MK, Cooper C, Chin-Fatt C, Pizzagalli DA, Trombello JM, Deckersbach T, Fava M, Weissman MM, Trivedi MH, Etkin A. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2020 Apr 1;77(4):397-408. doi: 10.1001/jamapsychiatry.2019.3867. PMID: 31895437; PMCID: PMC6990859. 5: Setya S, Madaan T, Razdan BK, Farswan M, Talegaonkar S. Design and Development of Novel Transdermal Nanoemulgel for Alzheimer's Disease: Pharmacokinetic, Pharmacodynamic and Biochemical Investigations. Curr Drug Deliv. 2019;16(10):902-912. doi: 10.2174/1567201816666191022105036. PMID: 31642410. 6: Sun X, Sun C, Zhai L, Dong W. A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice. Neurochem Res. 2019 Dec;44(12):2723-2732. doi: 10.1007/s11064-019-02891-5. Epub 2019 Oct 12. PMID: 31606838. 7: Reid SM, Westbury C, Guzys AT, Reddihough DS. Anticholinergic medications for reducing drooling in children with developmental disability. Dev Med Child Neurol. 2020 Mar;62(3):346-353. doi: 10.1111/dmcn.14350. Epub 2019 Sep 8. PMID: 31495925. 8: Kmet O, Filipets N, Kmet T, Hrachova T, Vepriuk Y. ENALAPRIL EFFECT ON GLUTATHIONE CHAIN OF THE ANTIOXIDANT SYSTEM OF THE BRAIN IN RATS WITH SCOPOLAMINE-INDUCED NEURODEGENERATION. Georgian Med News. 2019 Jun;(291):97-101. PMID: 31418740. 9: Fukuda T, Ayabe T, Ohya R, Ano Y. Matured hop bitter acids improve spatial working and object recognition memory via nicotinic acetylcholine receptors. Psychopharmacology (Berl). 2019 Sep;236(9):2847-2854. doi: 10.1007/s00213-019-05263-7. Epub 2019 May 8. PMID: 31069423. 10: Riva A, Giacomelli L, Togni S, Franceschi F, Eggenhoffner R, Zuccarini MC, Belcaro G. Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study. Minerva Gastroenterol Dietol. 2019 Mar;65(1):30-35. doi: 10.23736/S1121-421X.18.02530-8. PMID: 30676012. 11: Nile C, Falleni M, Cirasola D, Alghamdi A, Anderson OF, Delaney C, Ramage G, Ottaviano E, Tosi D, Bulfamante G, Morace G, Borghi E. Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections. mSphere. 2019 Jan 23;4(1):e00689-18. doi: 10.1128/mSphere.00689-18. PMID: 30674648; PMCID: PMC6344604. 12: Ni H, Chen SH, Li LL, Jin MF. Alterations in the Neurobehavioral Phenotype and ZnT3/CB-D28k Expression in the Cerebral Cortex Following Lithium- Pilocarpine-Induced Status Epilepticus: the Ameliorative Effect of Leptin. Biol Trace Elem Res. 2019 Jan;187(1):100-106. doi: 10.1007/s12011-018-1343-9. Epub 2018 Apr 23. PMID: 29687372. 13: Tapio HA, Raekallio MR, Mykkänen A, Mama K, Mendez-Angulo JL, Hautajärvi H, Vainio OM. Effects of MK-467 hydrochloride and hyoscine butylbromide on cardiorespiratory and gastrointestinal changes induced by detomidine hydrochloride in horses. Am J Vet Res. 2018 Apr;79(4):376-387. doi: 10.2460/ajvr.79.4.376. PMID: 29583040. 14: Wang D, Jiang Q, Du X. Protective effects of scopolamine and penehyclidine hydrochloride on acute cerebral ischemia-reperfusion injury after cardiopulmonary resuscitation and effects on cytokines. Exp Ther Med. 2018 Feb;15(2):2027-2031. doi: 10.3892/etm.2017.5646. Epub 2017 Dec 15. PMID: 29434800; PMCID: PMC5776622. 15: Zeng X, Chen S, Gao Q, Zong W, Jiang D, Zeng G, Zhou L, Chen L, Luo W, Xiao J, Xiao B, Ouyang D, Hu K. The expression of G protein-coupled receptor kinase 5 and its interaction with dendritic marker microtubule-associated protein-2 after status epilepticus. Epilepsy Res. 2017 Dec;138:62-70. doi: 10.1016/j.eplepsyres.2017.10.011. Epub 2017 Oct 13. Erratum in: Epilepsy Res. 2017 Dec 19;: PMID: 29080472. 16: Miyauchi M, Neugebauer NM, Sato T, Ardehali H, Meltzer HY. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats. J Psychopharmacol. 2017 Dec;31(12):1588-1604. doi: 10.1177/0269881117731278. Epub 2017 Sep 25. PMID: 28946779. 17: Hu J, Lai J, Hu S, Xu Y. Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia? Neuropsychiatr Dis Treat. 2017 Aug 31;13:2327-2330. doi: 10.2147/NDT.S143970. PMID: 28919765; PMCID: PMC5587161. 18: Li X, Wang H, Xu Y, Liu W, Gong Q, Wang W, Qiu X, Zhu J, Mao F, Zhang H, Li J. Novel Vilazodone-Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation. ACS Chem Neurosci. 2017 Dec 20;8(12):2708-2721. doi: 10.1021/acschemneuro.7b00259. Epub 2017 Sep 19. PMID: 28872831. 19: Belcaro G, Gizzi G, Pellegrini L, Corsi M, Dugall M, Cacchio M, Feragalli B, Togni S, Riva A, Eggenhoffner R, Giacomelli L. Supplementation with a lecithin- based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017 May;21(9):2249-2254. PMID: 28537656. 20: Malikowska N, Sałat K, Podkowa A. Comparison of pro-amnesic efficacy of scopolamine, biperiden, and phencyclidine by using passive avoidance task in CD-1 mice. J Pharmacol Toxicol Methods. 2017 Jul;86:76-80. doi: 10.1016/j.vascn.2017.04.006. Epub 2017 Apr 13. PMID: 28412329.